Mind Medicine (MindMed) Inc. (MNMD): Among the Best Psychedelic Stocks to Buy in 2025

Yahoo Finance11:11 ET

Earnings Preview: MNMD to Report Financial Results Pre-market on March 06

Moomoo NewsFeb 28 20:00 ET

Press Release: MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025

Dow JonesFeb 20 07:03 ET

MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025

Yahoo FinanceFeb 20 07:00 ET

$MNMD Stock Is up 13% Today. Here's What We See in Our Data.

Quiver QuantitativeFeb 14 10:31 ET

Atai CEO Rao Optimistic About Psychedelic Therapies Despite Lykos Setback

Seeking AlphaFeb 11 14:21 ET

Mind Medicine (MNMD) Advances Groundbreaking LSD Treatment

TipRanksFeb 6 04:12 ET

Mind Medicine Trading Higher After Zerohedge Compares to Oklo

TipRanksFeb 5 15:10 ET

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

WSJFeb 4 13:37 ET

MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

BusinesswireFeb 4 07:00 ET

Mind Medicine Doses First Patient in Panorama Study

Yahoo FinanceJan 31 07:20 ET

Optimistic Buy Rating for Mind Medicine's MM120 Amid Promising Phase 3 Progress and Strong Phase 2b Results

TipRanksJan 31 06:31 ET · Ratings

H.C. Wainwright Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $55

Moomoo NewsJan 31 06:31 ET · Ratings

Express News | Mind Medicine (MindMed) Inc - Topline Data Expected in Second Half of 2026

ReutersJan 30 07:01 ET

Express News | MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of Mm120 in Generalized Anxiety Disorder

ReutersJan 30 07:00 ET

HHS Secretary Nominee RFK Jr. Faces Contentious Senate Hearing

Seeking AlphaJan 29 15:54 ET

Mind Medicine: A Promising Bet in the Emerging Psychedelics Market With Regulatory Backing and Unique Approach

TipRanksJan 29 01:16 ET

Evercore Initiates Mind Medicine(MNMD.US) With Buy Rating, Announces Target Price $23

Moomoo NewsJan 28 07:34 ET · Ratings

This Westlake Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

BenzingaJan 28 07:18 ET

Evercore ISI Group Initiates Coverage On Mind Medicine With Outperform Rating, Announces Price Target of $23

BenzingaJan 28 06:44 ET · Ratings